VALEANT PHARMACEUTICALS INTERNATIONAL, INC. et al v. AIG INSURANCE COMPANY OF CANADA et al

  1. July 17, 2023

    Judge OKs Deal To End Allianz, Bausch Coverage Dispute

    A federal judge in New Jersey has signed off on a deal to end a coverage dispute between an Allianz unit and Bausch Health Cos. over whether the health company is entitled to coverage in class actions alleging an insider-trading scheme relating to a failed deal to take over pharmaceutical company Allergan PLC.

  2. January 06, 2023

    Allianz Can't Get Early Appeal Of Bausch's Coverage Win

    An Allianz unit can't yet ask the Third Circuit to weigh in on whether Bausch Health Cos. is entitled to coverage for class actions over an alleged insider trading scheme connected to its failed takeover of Allergan, a New Jersey federal court said.

  3. September 06, 2022

    Bausch Gets Partial Win In Coverage Fight Over Allergan Case

    Bausch Health Cos. received a win in its spat with insurers over coverage for class action suits the company faced in connection with its failed takeover of Allergan, with a New Jersey federal judge finding that the underlying actions count as covered "securities claims."

  4. July 01, 2020

    Bausch Not Covered For Allergan Case, Insurers Say

    Insurers for Bausch Health Cos. asked a New Jersey federal judge Wednesday to find that they don't have to pay the pharmaceutical company's costs to defend and settle class-action suits it faced over an alleged insider trading scheme connected to a failed takeover of Allergan, contending the suits are not covered "securities claims."

  5. April 24, 2020

    Bausch Says Insurers Can't Skirt Coverage For Allergan Case

    Bausch Health Cos. asked a New Jersey federal judge on Thursday to declare that claims it faced over an alleged insider trading scheme connected to a failed takeover of Allergan were covered by the company's insurance policies.

  6. January 12, 2018

    Valeant Says Insurers Must Defend Allergan, Stock-Drop Suits

    Valeant Pharmaceuticals has sued an AIG unit and other insurers, seeking coverage of its costs to defend lawsuits accusing it of orchestrating an insider trading scheme in connection with its attempted $55 billion takeover of Allergan and of fraudulently inflating its stock price, court documents filed Friday in New Jersey federal court show.